Company Overview and News

Transocean: Discussing April 2018 Fleet Status Report

2h seekingalpha
The season of fleet status reports has already begun, and it's high time to look at Transocean's (RIG) fleet status report. In Transocean's case, it looks like higher oil prices did not result in much contract activity. Without further ado, let's look at the contracts:
Upvote Downvote

Noble Corporation's 2024 Bonds Offer 8.75% Yield To Maturity

2018-04-18 seekingalpha
Noble Corporation (NE) saw a tremendous downturn in its business because of the energy recession. The company's stock prices plummeted, and bond prices fell into double digit yield territory. As the sector begins to recover, Noble's 2024 maturing bonds are still priced under par at 95 cents on the dollar. By factoring in the bond's coupon rate of 7.75%, the bonds are yielding 8.759% to maturity. The bond's coupon and yield offer a wonderful opportunity for fixed income investors looking to get in on the energy recovery.
Upvote Downvote

Noble has “normal operations”, or...? - ValueWalk

2018-04-17 valuewalk
Probably the most inusitate piece written by the cretins: A Noble MD states that Noble Group Shipping division, performs quarter after quarter, it’s the trading part who losts !
Upvote Downvote

Barnes & Noble: How We Manufactured 7% In A Month

2018-04-17 seekingalpha
On March 20, 2018, we bought shares of BKS at $5.04. We then sold BKS $5 4/20/2018 calls for $0.25 per contract.
Upvote Downvote

End of Era for Cocoa as Sucden Boss Stops Trading After 50 Years - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Stricken Noble Group seeks to reappoint founder Richard Elman to the board

The founder of commodities trader Noble Group could be in line for a shock return to the board after the stricken company revised its rescue plan.
Upvote Downvote

MOVES-Cravath M&A litigator Goldstein leaves for Kirkland & Ellis -sources

2018-04-13 reuters
April 13 (Reuters) - Sandra Goldstein, one of law firm Cravath, Swaine & Moore LLP’s most senior mergers and acquisitions litigation partners, has resigned to join rival law firm Kirkland & Ellis LLP, people familiar with the matter said on Friday.
Upvote Downvote

Energy Recap: Apple Comes Clean?

2018-04-13 seekingalpha
Every Friday, Seeking Alpha provides a roundup of insightful opinion and analysis articles in the energy sector.
Upvote Downvote

Noble Group reaches key creditor support threshold for deal

2018-04-13 themalaymailonline
An employee is reflected on the wall as she walks past a signage of Noble Resources, a Noble Group subsidiary, at their premises in Singapore March 6, 2015. — Reuters picSINGAPORE, April 13 — Creditor support for Noble Group Ltd’s restructuring has passed a key threshold, the company said, removing one source of uncertainty from the controversial deal on which the trading house’s survival depends.
Upvote Downvote

Noble Group Reaches Key Creditor Support Threshold for Deal - Bloomberg

2018-04-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Noble Corp. - Discussing The April Fleet Status Report

2018-04-12 seekingalpha
Shell opts to continue paying a standby rate for Noble Bully II, a warning sign in a $70 Brent oil world.
Upvote Downvote

Barnes & Noble must face renewed data breach lawsuit: U.S. appeals court

2018-04-11 reuters
(Reuters) - A federal appeals court revived a lawsuit seeking to hold Barnes & Noble Inc (BKS.N) responsible for customer losses from a 2012 data breach, where fraudsters tampered with payment verification machines known as PIN pads at 63 bookstores in nine U.S. states.
Upvote Downvote

Noble Restructuring in Doubt as Founder Pushes for New Deal - Bloomberg

2018-04-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Noble Group's nemesis returns to warn rescue deal has ‘zero chance’

Stricken commodities trader Noble Group is on the ropes once again after its nemesis, an anonymous research group named Iceberg, warned its rescue plan had “zero chance of success”.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 65504R104